Valtech’s valuation team has recently completed a valuation for an international pharmaceutical group for its investments in European countries. We are glad to be a trusted valuation firm for delivering valuation opinion to clients from the life sciences and health care industry.
We have facilitated our client to evaluate the risk-adjusted rewards on potential investment and the recoverability of acquired and established business with scale of hundreds of millions in EUR. Market and industry benchmarking studies have been conducted to derive and support our conclusions.
We have worked with both the European and Asian hubs of the group and dealt with enquires from the respective regional audit teams of an international audit firm. We have created additional value to ensure consistent, effective and seamless communication between their regional leaderships on the subject issues.
